CVRX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.29 USD | +2.60% |
|
+14.03% | -73.63% |
| 02/05 | North American Morning Briefing : Stock Futures -3- | DJ |
| 01/05 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Presentation Operator MessageOperator (Operator)Greetings, and welcome to the CVRx Q1 2024 Ear...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programed by a wireless clinician-controlled programmer that communicates with the IPG.
Calendar
04/06/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
8.29
USD
Average target price
16.6
USD
Spread / Average Target
+100.24%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -73.63% | 174M | |
| +73.24% | 12.42B | |
| -19.09% | 7.81B | |
| +5.88% | 6.4B | |
| +13.24% | 5.45B | |
| +38.48% | 5.01B | |
| -17.30% | 4.84B | |
| -19.78% | 4.19B | |
| -29.53% | 2.69B | |
| +47.29% | 2.39B |
- Stock Market
- Equities
- CVRX Stock
- News CVRx, Inc.
- Transcript : CVRx, Inc., Q1 2024 Earnings Call, Apr 30, 2024
